Pilot Study of New Computer-based Neuropsychological Tool: Visual Tests, Touch Responses

Not Applicable

Completed

• Conditions: Cerebral Neurological Illness

• Registration Number: NCT03502603
• Lead Sponsor: NYU Langone Health

Brief Summary

This study is aimed at investigating three new tests that will form part of a computerized tool designed to test brain/cognitive functioning. The system will be evaluated along with the tests' usability on samples of healthy controls and neurologically impaired patient participants. These new tests will be assessed with regard to reliability and validity. Reliability will be addressed through investigation of internal consistency of the test items. Validity will be evaluated relative to traditional paper-and-pencil tests and differentiation between patient and healthy participants.Each participant will complete both the computerized and paper and pencil-based tests. The results will be analyzed to see how performances on the two test types compare. The overall aim of this project is to determine if these new computerized tasks are an improvement over standard paper and pencil-based neuropsychological measures.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-04-11
• Study First Submitted QC: 2018-04-11
• Study First Posted: 2018-04-18
• Study Start: 2019-05-10
• Primary Completion: 2023-12-06
• Study Completion: 2023-12-06
• Status Verified: 2025-04
• Last Update Submitted: 2025-04-08
• Last Update Posted: 2025-04-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 137

Inclusion Criteria

Individuals without positive cerebral findings on neuroimaging (Non-PCF)

• Participants can be male or female and between the ages of 21 and 65 years old.
• Participants will have adequate perceptual and motor capabilities to participate in testing.

Neuroimaging-positive cerebral findings (PCF)

• Patients at NYULMC identified to have significant cerebral findings on neuroimaging.
• Participants will be male or female and between the ages of 21 and 65 years old.
• Participants will have adequate perceptual and motor capabilities to participate in testing.

Exclusion Criteria

• Participants without adequate perceptual and motor capacities preventing them from participation in the testing.
• Participants with severe dysfunction at the level of dementia that can interfere with informed consent.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Score on Railroad Test	1 Day
Score on President Recognition Test	1 Day
Score on Swamp Test	1 Day

Trial Locations

Locations (1)

New York University School of Medicine; 🇺🇸 New York, New York, United States